FCOMV

Foresite Capital Opportunity Management V Portfolio holdings

AUM $33.3M
1-Year Est. Return 46.98%
This Quarter Est. Return
1 Year Est. Return
-46.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$39.7M
AUM Growth
-$31.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

1 +$2.71M
2 +$1.39M
3 +$1.2M

Top Sells

1 +$4.14M
2 +$3.46M
3 +$2.24M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$16M 40.44%
5,227,307
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.3M 13.37%
959,275
+490,455
CMPX icon
3
Compass Therapeutics
CMPX
$642M
$4.12M 10.38%
1,554,250
+454,250
IRON icon
4
Disc Medicine
IRON
$3.17B
$4.12M 10.37%
81,171
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.68M 9.27%
291,667
ACET icon
6
Adicet Bio
ACET
$112M
$2.48M 6.26%
170,000
QSI icon
7
Quantum-Si Incorporated
QSI
$428M
$1.47M 3.7%
633,626
-964,499
HIMS icon
8
Hims & Hers Health
HIMS
$10B
$1.39M 3.5%
+306,431
ENTA icon
9
Enanta Pharmaceuticals
ENTA
$312M
$1.07M 2.71%
22,750
CGEM icon
10
Cullinan Oncology
CGEM
$461M
-330,836
HLTH
11
DELISTED
Cue Health Inc. Common Stock
HLTH
-641,483